Single-Cell Transcriptomic Analysis Reveals BCMA CAR-T Cell Dynamics in a Patient with Refractory Primary Plasma Cell Leukemia
Authors:
Open Access
- 1 February 2021
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 29 (2) , 645-657
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81770201)
- National Natural Science Foundation of China (81870153)
- National Natural Science Foundation of China (81730008)
- National Natural Science Foundation of China (81970137)
- National Natural Science Foundation of China (31871453)
- National Natural Science Foundation of China (91857116)
- Science and Technology Program of Zhejiang Province (2019C03016,2018C03016-2)
- Science and Technology Department of Zhejiang Province
- National Key Research and Development Program of China (2018YFA0107103)
- National Key Research and Development Program of China (2018YFC1005002)
- National Key Research and Development Program of China (2018YFA0107100)
This publication has 39 references indexed in Scilit:
- Clonal kinetics and single-cell transcriptional profiling of CAR-T cells in patients undergoing CD19 CAR-T immunotherapyNature Communications, 2020
- Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALLBlood, 2019
- Anti-BCMA CAR T-cell therapy in multiple myeloma: can we do better?Leukemia, 2019
- CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemiaLeukemia, 2019
- Single-Cell Analysis of CAR-T Cell Activation Reveals A Mixed TH1/TH2 Response Independent of DifferentiationGenomics, Proteomics & Bioinformatics, 2019
- Plasma Cell Leukemia: Definition, Presentation, and TreatmentCurrent Oncology Reports, 2019
- T Cells Genetically Modified to Express an Anti–B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple MyelomaJournal of Clinical Oncology, 2018
- Chimeric Antigen Receptor TherapyNew England Journal of Medicine, 2018
- Single-cell multiplexed cytokine profiling of CD19 CAR-T cells reveals a diverse landscape of polyfunctional antigen-specific responseJournal for ImmunoTherapy of Cancer, 2017
- Potent Anti-leukemia Activities of Chimeric Antigen Receptor–Modified T Cells against CD19 in Chinese Patients with Relapsed/Refractory Acute Lymphocytic LeukemiaClinical Cancer Research, 2017